China Pharma Holdings (CPHI) Current Taxes (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Current Taxes came in at $377372.0 in Q2 2026, down 49.1% on a YoY basis from $741376.0 in Q2 2025, and up 1.94% quarter-over-quarter from $370174.0 in Q1 2026.
Analysis
China Pharma Holdings (CPHI) Current Taxes (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported Current Taxes for 8 consecutive years, with $377372.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Taxes fell 49.1% year-over-year to $377372.0; the trailing twelve-month figure through Jun 2026 stood at $377372.0 (down 49.1% YoY), and the FY2025 full-year result was $351904.0, down 20.21% from the prior year.
- Current Taxes rose to $377372.0 in Q2 2026 per CPHI's latest filing, from $370174.0 in the prior quarter.
- Across five years, Current Taxes topped out at $1.0 million in Q4 2023 and bottomed at $351904.0 in Q4 2025.
- Historically, Current Taxes has averaged $550567.2 across 4 years, with a median of $441062.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Current Taxes tumbled 57.06% in 2024, then soared 73.26% in 2025.
- Over 4 years, Current Taxes stood at $1.0 million in 2023, then sank by 57.06% to $441062.0 in 2024, then decreased by 20.21% to $351904.0 in 2025, then rose by 7.24% to $377372.0 in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $377372.0, $370174.0, and $351904.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 653.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.03 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | 377,372.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 377,372.00 |
| Mar 31, 2026 | 370,174.00 |
| Dec 31, 2025 | 351,904.00 |
| Sep 30, 2025 | 691,677.00 |
| Jun 30, 2025 | 741,376.00 |
| Mar 31, 2025 | 555,142.00 |
| Dec 31, 2024 | 441,062.00 |
| Sep 30, 2024 | 399,212.00 |
| Dec 31, 2023 | 1.03 Mn |
| Jun 30, 2013 | 690,781.00 |
| Mar 31, 2013 | 514,245.00 |
| Dec 31, 2012 | 2.43 Mn |
| Sep 30, 2012 | 3.02 Mn |
| Jun 30, 2012 | 3.27 Mn |
| Mar 31, 2012 | 3.54 Mn |
| Dec 31, 2011 | 3.08 Mn |
| Sep 30, 2011 | 3.30 Mn |
| Jun 30, 2011 | 3.36 Mn |
| Dec 31, 2010 | 2.39 Mn |